Arrowstreet Capital, Limited Partnership Seres Therapeutics, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$7.33 - $9.23 $106,717 - $134,379	-14,559 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$6.91 - $9.55 $253,797 - $350,761	-36,729 Reduced 71.61%	14,559 $125,000
Q1 2018 May 14, 2018	BUY	$7.34 - $11.16 $272,959 - $415,018	37,188 Added 263.74%	51,288 $376,000
Q4 2017 Feb 09, 2018	BUY	$9.15 - $12.64 $129,015 - $178,224	14,100	14,100 $143,000

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $68.2M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.